Cite
Ferron PJ, Le Daré B, Bronsard J, et al. Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010082.
Ferron, P. J., Le Daré, B., Bronsard, J., Steichen, C., Babina, E., Pelletier, R., Hauet, T., Morel, I., Tarte, K., Reizine, F., Clément, B., Fromenty, B., & Gicquel, T. (2021). Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010082
Ferron, Pierre-Jean, et al. "Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010082
Ferron PJ, Le Daré B, Bronsard J, Steichen C, Babina E, Pelletier R, Hauet T, Morel I, Tarte K, Reizine F, Clément B, Fromenty B, Gicquel T. Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients. Int J Mol Sci. 2021 Dec 22;23(1). doi: 10.3390/ijms23010082. PMID: 35008505.
Copy
Download .nbib